Singapore Exchange divests Scientific Beta to STOXX

SGX Filings
07/08

On Jul, 8 2026, Singapore Exchange (S68) announced the sale of its wholly owned subsidiary, Scientific Beta, to STOXX Ltd.

The transaction is part of SGX Group’s strategy of active portfolio management and capital allocation, allowing the bourse operator to redirect resources toward areas that reinforce its multi-asset franchise in securities, derivatives and data.

SGX Group said it will retain its global multi-asset iEdge platform and continue to expand its index business as a core component of its wider offering.

Head of Global Financial Markets Ng Yao Loong stated that the divestment will enable SGX Group to concentrate on opportunities with the greatest potential impact for clients, partners and shareholders while positioning Scientific Beta for its next phase of growth under new ownership.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10